DCCR Tablets Reduce Body Fat in PWS Patients, Phase 2 Trial Shows Prader-Willi News
A phase 2 clinical trial showed DCCR tablets can treat excessive eating and behavioral problems of Prader-Willi syndrome patients, plus reduce body fat.
DCCR Tablets Reduce Body Fat in PWS Patients, Phase 2 Trial Shows Prader-Willi News
A phase 2 clinical trial showed DCCR tablets can treat excessive eating and behavioral problems of Prader-Willi syndrome patients, plus reduce body fat.